Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections.

ABSTRACT: Introduction: Suppressive antibiotic therapy (SAT) is a therapeutic alternative for complex infections where a cure is considered unlikely or impossible. SAT involves the prolonged, often indefinite, administration of antibiotics, typically given orally, to control symptoms. However, the increasing incidence of multidrug-resistant microorganisms limits the availability of oral options. Dalbavancin is a parenteral antibiotic with broad coverage against Gram-positive bacteria that offers the advantage of an extended dosing interval. The aim of this study was to describe the characteristics and clinical outcomes of patients with implant-associated osteoarticular infections receiving dalbavancin as SAT. A secondary objective was to identify factors associated with SAT failure with dalba

SUBMITTER: Escudero-Sanchez R 

PROVIDER: S-EPMC12649215 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature